Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

NCT00509262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Renal Insufficiency, Chronic

Interventions

DRUG: Sitagliptin
DRUG: Glipizide
DRUG: Placebo for Sitagliptin
DRUG: Placebo for Glipizide

Sponsor

Merck Sharp & Dohme LLC